Longevity Health Holdings Announces Continued Nasdaq Listing to Complete Merger With 20/20 Biolabs
PITTSBURGH, May 21, 2025 (GLOBE NEWSWIRE) -- Longevity Health Holdings, Inc. (Nasdaq:…
Moody’s Investor Services Upgrades Teva Amid Continued Success of Pivot to Growth Strategy
TEL AVIV, Israel, May 15, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals (NYSE…
Niall Prendiville Joins CSafe as Chief Product Officer to Drive Continued Growth in Innovation Across the Product Portfolio
Prendiville brings over 25 years of expertise in product, engineering, automation and…
Golden Gate Global Reaches 400 I-829 Approvals, Showcasing Continued Excellence
SAN FRANCISCO, April 29, 2025 /PRNewswire/ -- Golden Gate Global (GGG), a…
Shanghai Electric Reports Continued Growth in 2024 as Its Clean Energy and High-End Equipment Push Expands
With Revenue, Gross Margin, Order Volume, and Cash Flow All Achieving Simultaneous…
EcoVadis recognizes Quest Global’s continued progress on sustainability; awarded ‘Commitment Badge’ in the sustainability assessment
BENGALURU, India, April 15, 2025 /PRNewswire/ -- Quest Global, a leading global…
Urgently Notified By Nasdaq Of Non-Compliance With Nasdaqs Continued Listing Standards
Intends to Submit Compliance Plan to Nasdaq March 24, 2025 17:00 ET…
Curia Announces Strategic Refinancing to Support Continued Growth
ALBANY, N.Y., March 07, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia),…
Thriving and Flourishing Throughout 2024, Plum Sets Sights on Continued Growth in 2025
NEW YORK, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Reflecting on the company’s…
Three-Year Results for EYLEA HD (aflibercept) Injection 8 mg in Patients with Wet Age-related Macular Degeneration Demonstrate Continued Durable Vision Gains and Anatomic Improvements with Extended Dosing Intervals
At three years of EYLEA HD treatment, the vast majority of patients…